Auranofin: its use in patients with rheumatoid arthritis maintained with parenteral chrysotherapy
Blackburn, W.D.
Journal of Rheumatology 14(4): 863-864
1987
ISSN/ISBN: 0315-162X PMID: 3669000 Document Number: 288035
Document emailed within 1 workday
Related Documents
Pole, D.J.; Balazs, N.D.; Maserai, J. 1971: Plasma gold estimations in patients receiving chrysotherapy for rheumatoid arthritis Medical Journal of Australia 2(23): 1181-1183Michaels, R.M.; Reading, J.C.; Beezhold, D.H.; Ward, J.R. 1996: Serum phospholipase A2 activity in patients with rheumatoid arthritis before and after treatment with methotrexate, auranofin, or combination of the two Journal of Rheumatology 23(2): 226-229
Di Matteo, L.; D'Incecco, V.; Evangelista, L.; Castiglione, C.; Consoli, G. 1985: Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin) Bollettino della Societa Italiana di Biologia Sperimentale 61(5): 777-781
Champion, G.D.; Bieri, D.; Browne, C.D.; Day, R.O.; Graham, G.G.; Haavisto, T.M.; Sambrook, P.N.; Vallance, J.B. 1982: Auranofin in rheumatoid arthritis Journal of Rheumatology. Suppl 8: 137-145
Yamanaka, K.; Yamada, O.; Yamazaki, S. 1971: In vivo transport of gold in chrysotherapy of rheumatoid arthritis Rinsho Byori. Japanese Journal of Clinical Pathology 19(1): 68-73
Finkelstein, A.E.; Roisman, F.R.; Batista, V.; de Nudelman, F.G.; de Titto, E.H.; Mizraji, M.; Walz, D.T. 1980: Oral chrysotherapy in rheumatoid arthritis: minimum effective dose Journal of Rheumatology 7(2): 160-168
Pegg, S.J.; Lang, B.A.; Mikhail, E.L.; Hughes, D.M. 1994: Fatal bronchiolitis obliterans in a patient with juvenile rheumatoid arthritis receiving chrysotherapy Journal of Rheumatology 21(3): 549-551
Glennås, A.; Kvien, T.K.; Rugstad, H.E. 1986: Auranofin (Ridaura). a new peroral agent containing gold used in the treatment of rheumatoid arthritis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(29): 2438-2440
Champion, G.D.; Cairns, D.R.; Bieri, D.; Adena, M.A.; Browne, C.D.; Cohen, M.L.; Day, R.O.; Edmonds, J.P.; Graham, G.G.; de Jager, J. 1988: Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis Journal of Rheumatology 15(1): 28-34
Yang, J.L. 1993: Auranofin in the treatment of rheumatoid arthritis: a multicenter double-blind prospective clinical trial Zhonghua Nei Ke Za Zhi 32(7): 486-488
Kuz'mina, N.N.; Brue, E.; Shaĭkov, A.V.; Isaeva, L.A.; Shakhbazian, I.E.; Giannini, E.; Iakovleva, A.A.; Puodzhiunene, E.P.; Vorontsov, I.M.; Astrauskene, D.S. 1990: The evaluation of the therapeutic efficacy of auranofin in juvenile rheumatoid arthritis (the results of Soviet-American research) Terapevticheskii Arkhiv 62(5): 38-41
Boiardi, L.; Macchioni, P.; Salvarani, C.; Rossi, F.; Casadei-Maldini, M.; Mancini, R.; Beltrandi, E.; Portioli, I. 1994: Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment Clinical and Experimental Rheumatology 12(4): 357-362
Masson, C.; Renier, J.C.; Robert, C.; Emile, J.; Brégeon, C. 1989: Morvan's fibrillary chorea in patients on chrysotherapy for rheumatoid polyarthritis Revue du Rhumatisme et des Maladies Osteo-Articulaires 56(1): 27-30
Yazici, Y.; Bata, Y. 2013: Parenteral methotrexate for the treatment of rheumatoid arthritis Bulletin of the Hospital for Joint Disease 71(Suppl 1): 46-48
Suarez-Almazor, M.E.; Russell, A.S. 1990: Parenteral methotrexate or gold for rheumatoid arthritis: a follow up Clinical and Experimental Rheumatology 8(2): 163-166
Morris, C.R.; Morris, A.J. 1993: Localized lymphoma in a patient with rheumatoid arthritis treated with parenteral methotrexate Journal of Rheumatology 20(12): 2172-2173
Yu, C.; Li, M.; Duan, X.; Fang, Y.; Li, Q.; Wu, R.; Liu, S.; Wang, Y.; Wu, Z.; Shi, X.; Jiang, Z.; Wang, Y.; Hsieh, E.D.; Jin, S.; Jiang, N.; Wang, Q.; Zhao, Y.; Tian, X.; Zeng, X. 2018: Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis Clinical and Experimental Rheumatology 36(5): 836-840
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Førre, O.; Dobloug, J.H.; Natvig, J.B. 1982: Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction Scandinavian Journal of Immunology 15(2): 227-231
Vlak, T.; Jajić, I. 1992: The effect of gold salts on rheumatoid factor dynamics in patients with rheumatoid arthritis Reumatizam 39(1): 11-13